Drug Profile
Research programme: analgesics - Xenome
Alternative Names: XenKappaLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Xenome
- Class Peptides
- Mechanism of Action Opioid kappa receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in Australia (Parenteral)
- 10 Mar 2010 Preclinical trials in Pain in Australia (Parenteral)